| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 840,502 | 768,356 | 894,073 | 1,210,107 | | Cost of Revenue | 687,799 | 634,652 | 754,330 | 1,013,826 | | | Gross Profit | 152,703 | 133,704 | 139,743 | 196,281 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 116,992 | 102,130 | 111,613 | 128,252 | | Non Recurring |
-
| 1,231 | 112,808 |
-
| | Others | 13,303 | 12,491 | 13,153 | 14,185 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 22,408 | 17,852 | (97,831) | 53,844 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,437 | 2,521 | 2,261 | 5,459 | | Earnings Before Interest And Taxes | 23,845 | 20,373 | (95,570) | 59,303 | | Interest Expense | 4,531 | 6,176 | 7,058 | 8,503 | | Income Before Tax | 19,314 | 14,197 | (102,628) | 50,800 | | Income Tax Expense | 5,907 | 4,317 | (12,180) | 14,237 | | Minority Interest | (1,652) | (35) | 642 | (770) | | | | Net Income From Continuing Ops | 11,755 | 9,845 | (89,806) | 35,793 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 2,088 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 11,755 | 9,845 | (89,806) | 37,881 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $11,755 | $9,845 | ($89,806) | $37,881 |
|
0.29% Nasdaq 
0.20 (1.47%) 
Income Statement
